Company Profile

Aeris Therapeutics Inc
Profile last edited on: 6/17/21      CAGE: 4RRC1      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2000
First Award
2004
Latest Award
2007
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

10K Gill Street
Woburn, MA 01801
   (781) 937-0110
   aeris@aerist.com
   www.aerist.com
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

In January 2015 the assets of Aeris Therapeutics Inc. were put up fro auction and was acquired by Pulmonx Corporation. Aeris now functions as a subsiduary of that firm. Aeris Therapeutics, Inc. had been developing novel treatments for patients with advanced lung disease. The Company’s lead product is a Bronchoscopic Lung Volume Reduction (BLVR) System for the treatment of emphysema. Reduction of lung volume by surgical resection of tissue is an accepted therapy for patients with advanced emphysema. The BLVR System is designed to reduce lung volume non-surgically, by promoting collapse and contraction of the diseased lung tissue. Reduction of lung volume generates more space within the chest cavity, allowing healthier lung tissue to expand and improving lung function and breathing mechanics.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2007 2 NIH $1,200,484
Project Title: Pneumedoreductive Surfacant - New Therapy for Emphysema
2005 1 NIH $100,000
Project Title: Enzymatic Pleurodesis for Malignant Pleural Effusions

Key People / Management

  David Dove -- President

  Edward P Ingenito -- Founder, Chief Scientific Officer, Medical Director

  Larry W Tsai

Company News

There are no news available.